These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11385492)

  • 1. The allogeneic response and tumor immunity.
    Fabre JW
    Nat Med; 2001 Jun; 7(6):649-52. PubMed ID: 11385492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC restriction and allogeneic immune responses.
    Kazansky DB
    J Immunotoxicol; 2008 Oct; 5(4):369-84. PubMed ID: 19404871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a home-grown T cell receptor interacts with a foreign landscape.
    Rossjohn J; McCluskey J
    Cell; 2007 Apr; 129(1):19-20. PubMed ID: 17418777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host factors in the pathogenesis of arthritis triggered by infectious organisms. Overview.
    Koopman WJ
    Rheum Dis Clin North Am; 1993 May; 19(2):279-92. PubMed ID: 8502772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incompatible differences: view of an allogeneic pMHC-TCR complex.
    Kranz DM
    Nat Immunol; 2000 Oct; 1(4):277-8. PubMed ID: 11017095
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular bases of cancer immunology].
    Barrera-Rodríguez R; Peralta-Zaragoza O; Madrid-Marina V
    Salud Publica Mex; 1995; 37(4):344-53. PubMed ID: 7502157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of alloreactive T cells is a consequence of the presentation of many peptides by allogeneic MHC molecules.
    Salom R; Brookes P; Hornick P; Lechler R
    Transplant Proc; 1995 Dec; 27(6):3579. PubMed ID: 8540111
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cell allorecognition: a case of mistaken identity or déjà vu?
    Archbold JK; Macdonald WA; Burrows SR; Rossjohn J; McCluskey J
    Trends Immunol; 2008 May; 29(5):220-6. PubMed ID: 18378495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.
    Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K
    Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting beneficial alloreactive T cells.
    Barber LD; Madrigal JA
    Vox Sang; 2006 Jul; 91(1):20-7. PubMed ID: 16756597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG; Timmermann W; Ulrichs K; Otto C
    Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of the immune response by HLA molecules].
    Sterkers G; Zeliszewski D; Eljaafari-Corbin A
    Ann Rech Vet; 1992; 23(3):265-8. PubMed ID: 1416733
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of tumor immunity following allogeneic stem cell transplantation.
    Wu CJ; Ritz J
    Adv Immunol; 2006; 90():133-73. PubMed ID: 16730263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA polymorphism: the origin of individual response in immunity].
    Takata H; Uchiyama T; Inoko H
    Tanpakushitsu Kakusan Koso; 1996 Nov; 41(15 Suppl):2355-68. PubMed ID: 8952398
    [No Abstract]   [Full Text] [Related]  

  • 19. MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.
    Provenzano M; Panelli MC; Mocellin S; Bracci L; Sais G; Stroncek DF; Spagnoli GC; Marincola FM
    Trends Mol Med; 2006 Oct; 12(10):465-72. PubMed ID: 16962375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell immunity and graft-versus-host disease (GVHD).
    Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
    Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.